Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,753
datasets available to search
ShareScore release 0.9.0
Dataset results
2,753 results for “NSCLC”
Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04379635. IPD Sharing: YES. Countries: 1. Publications: 2.
Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M
ClinicalTrials.gov study NCT03133546. IPD Sharing: NO. Countries: 6. Publications: 6.
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
ClinicalTrials.gov study NCT05338970. IPD Sharing: YES. Countries: 21. Publications: 2.
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC
ClinicalTrials.gov study NCT03215706. IPD Sharing: Not stated. Countries: 19. Publications: 3.
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L
ClinicalTrials.gov study NCT02864251. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC
ClinicalTrials.gov study NCT03607539. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03296163. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
ClinicalTrials.gov study NCT05215340. IPD Sharing: YES. Countries: 28. Publications: 1.
Supportive Care Mobile Application for Patients With NSCLC
ClinicalTrials.gov study NCT04629300. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
ClinicalTrials.gov study NCT03334617. IPD Sharing: YES. Countries: 8. Publications: 1.
A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
ClinicalTrials.gov study NCT04550104. IPD Sharing: YES. Countries: 1. Publications: 3.
Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Plati
ClinicalTrials.gov study NCT03976375. IPD Sharing: YES. Countries: 18. Publications: 3.
Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC
ClinicalTrials.gov study NCT00824408. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)
ClinicalTrials.gov study NCT04248829. IPD Sharing: YES. Countries: 13. Publications: 2.
A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC
ClinicalTrials.gov study NCT02346370. IPD Sharing: NO. Countries: 1. Publications: 1.
Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04051827. IPD Sharing: NO. Countries: 3. Publications: 0.
Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC
ClinicalTrials.gov study NCT02709720. IPD Sharing: NO. Countries: 1. Publications: 1.
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC
ClinicalTrials.gov study NCT03141359. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02453282. IPD Sharing: YES. Countries: 17. Publications: 2.
Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy
ClinicalTrials.gov study NCT00364351. IPD Sharing: Not stated. Countries: 22. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.